论文部分内容阅读
(一)形势严峻改革开放以来,我国国有医药商业获得了长足发展,经营设施不断完善,经营规模越来越大,商品购销逐年上升,服务质量和服务水平进一步提高,从而保障了广大群众医疗保健需要,为防疫急救、抢险救灾、支援工农业生产,保障人民健康做出了重要贡献。但是,近年来,医药商业经营工作遇到了重重困难,商品销售下降,资金周转缓慢,费用水平提高,经济效益严重滑坡。1994年全国医药商业销售净值612亿元,比上年下降13.4%,实际费用水平15.37%,比上年提高4.35个百分点,实现利税17.3亿元,比上年减少28.4
(I) The situation is grim Since the reform and opening up, China’s state-owned pharmaceutical business has achieved rapid development, its operating facilities have been continuously improved, its business scale has grown and the purchase and sales of goods have been increasing year by year, and service quality and service levels have been further improved, thus protecting the health care of the masses. Needs have made important contributions to epidemic prevention, emergency rescue and disaster relief, support for industrial and agricultural production, and protection of people’s health. However, in recent years, medical and commercial operations have encountered difficulties, the sales of commodities have fallen, the turnover of funds has been slow, the cost level has increased, and the economic efficiency has been severely declining. In 1994, the net value of pharmaceutical sales nationwide was 61.2 billion yuan, a decrease of 13.4% over the previous year, the actual cost level was 15.37%, an increase of 4.35 percentage points over the previous year, and the profit and taxation was 1.73 billion yuan, a decrease of 28.4 years over the previous year.